Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does DENOSUMAB Cause Blood alkaline phosphatase increased? 142 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 142 reports of Blood alkaline phosphatase increased have been filed in association with DENOSUMAB (Bilprevda). This represents 0.1% of all adverse event reports for DENOSUMAB.

142
Reports of Blood alkaline phosphatase increased with DENOSUMAB
0.1%
of all DENOSUMAB reports
15
Deaths
34
Hospitalizations

How Dangerous Is Blood alkaline phosphatase increased From DENOSUMAB?

Of the 142 reports, 15 (10.6%) resulted in death, 34 (23.9%) required hospitalization, and 2 (1.4%) were considered life-threatening.

Is Blood alkaline phosphatase increased Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for DENOSUMAB. However, 142 reports have been filed with the FAERS database.

What Other Side Effects Does DENOSUMAB Cause?

Off label use (34,612) Death (16,545) Osteonecrosis of jaw (8,438) Arthralgia (5,890) Pain in extremity (4,541) Back pain (4,465) Pain (4,102) Product storage error (3,621) Fall (3,322) Fatigue (3,009)

What Other Drugs Cause Blood alkaline phosphatase increased?

TERIPARATIDE (372) FINGOLIMOD (332) ACETAMINOPHEN (331) NIVOLUMAB (301) RITUXIMAB (293) RIBOCICLIB (289) ASFOTASE ALFA (283) METHOTREXATE (272) LETROZOLE (266) ATORVASTATIN (262)

Which DENOSUMAB Alternatives Have Lower Blood alkaline phosphatase increased Risk?

DENOSUMAB vs DEOXYCHOLIC ACID DENOSUMAB vs DEPAKINE CHRONO DENOSUMAB vs DEPAKOTE DENOSUMAB vs DEPO-PROVERA DENOSUMAB vs DERMATOPHAGOIDES FARINAE

Related Pages

DENOSUMAB Full Profile All Blood alkaline phosphatase increased Reports All Drugs Causing Blood alkaline phosphatase increased DENOSUMAB Demographics